Copertina

Unveiling causal relationships between inflammatory cytokines and neurite orientation dispersion and density imaging phenotypes: Insights from bidirectional Mendelian randomization and bibliometric analysis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Longtao Yang, Wantong Xu, Yihui Tang, Ben Wu, Xuemei Wang, Jun Liu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Psychiatry and Clinical Neurosciences
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Brain structural connectivity and psychiatric disorders: A Mendelian randomization–based examination of bidirectional causal relationships
di: Kazutaka Ohi
Pubblicazione: (2025)

Mendelian randomization analyses uncover causal relationships between brain structural connectome and risk of psychiatric disorders
di: Kanwei Xiao, et al.
Pubblicazione: (2025)

Response to ‘Potential role of anti‐inflammatory cytokines in postpartum depression: Considerations for future research and improvement’
di: Chiaki T. Ono, et al.
Pubblicazione: (2024)

Association between serum cytokines and timeframe for conversion from clinical high‐risk to psychosis
di: TianHong Zhang, et al.
Pubblicazione: (2024)

Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [18F]SynVesT‐1
di: Ling Xiao, et al.
Pubblicazione: (2024)

Corticostriatal causality analysis in children and adolescents with attention‐deficit/hyperactivity disorder
di: Fanyu Zhang, et al.
Pubblicazione: (2024)

Sleep and circadian disruption in bipolar disorders: From psychopathology to digital phenotyping in clinical practice
di: André C. Tonon, et al.
Pubblicazione: (2024)

Digital phenotyping of social functioning and employment in people with schizophrenia: Pilot data from an international sample
di: Erlend Lane, et al.
Pubblicazione: (2025)

Short tandem repeat expansions in cortical layer‐specific genes implicate in phenotypic severity and adaptability of autism spectrum disorder
di: Jae Hyun Kim, et al.
Pubblicazione: (2024)

Assessing glymphatic function in schizophrenia and mood disorders: Insights from a diffusion tensor image along the perivascular space ( DTI ‐ ALPS ) and neuroanatomical correlations
di: Jun‐Ding Zhu, et al.
Pubblicazione: (2025)

Cognitive profile of psychiatric patients with coexisting enlarged ventricles and cognitive impairment: A rare cross‐diagnostic phenotype predominantly observed in schizophrenia
di: Junya Matsumoto, et al.
Pubblicazione: (2025)

Homogenization of word relationships in schizophrenia: Topological analysis of cortical semantic representations
di: Ryusuke Hayashi, et al.
Pubblicazione: (2024)

The relationship between depression, anxiety, and disability in patients with multiple sclerosis: A cross‐sectional study from western Iran
di: Nazanin Razazian, et al.
Pubblicazione: (2026)

Synthetic image evolution for affective science
di: Darius Valevicius, et al.
Pubblicazione: (2026)

Psychotherapy and inhibitory control: Insights from fMRI research
di: Gioele Gavazzi, et al.
Pubblicazione: (2026)

Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies
di: Tsutomu Takeda, et al.
Pubblicazione: (2025)

Efficacy and safety of a digital therapeutic for alcohol dependence: A multicenter, open‐label, randomized controlled trial
di: Ryuhei So, et al.
Pubblicazione: (2025)

AST‐001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial
di: Hyo‐Won Kim, et al.
Pubblicazione: (2024)

Genomic architecture of bipolar disorder in Japan: Insights from genomic structural equation modeling
di: Hiroki Kimura, et al.
Pubblicazione: (2025)

Public acceptance and expectations for Lecanemab: Insights from a Smallest Worthwhile Difference study
di: Aran Tajika, et al.
Pubblicazione: (2026)

Clinical and imaging correlates of hyperorality in syndromes associated with frontotemporal lobar degeneration
di: Daniele Altomare, et al.
Pubblicazione: (2024)

Potential placebo bias in current trials of delirium prevention: a network meta‐analysis of 86 randomized controlled trials
di: Bing‐Yan Zeng, et al.
Pubblicazione: (2025)

Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate
di: Chieh‐Hsin Lin, et al.
Pubblicazione: (2025)

Correction to “ AST ‐001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial”
Pubblicazione: (2025)

Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with moderate to severe cognitive impairment: A randomized controlled trial
di: Jing Li, et al.
Pubblicazione: (2025)

Association between anticipated follow‐up duration and treatment outcomes in anorexia nervosa: Insights from a Japanese medical prison
di: Wataru Nakagawa, et al.
Pubblicazione: (2026)

Identification of schizophrenia by applying interpretable radiomics modeling with structural magnetic resonance imaging of the cerebellum
di: Minji Bang, et al.
Pubblicazione: (2024)

Association of objective body shape and perceived body image with depressive symptoms in men and women
di: Seong‐Uk Baek, et al.
Pubblicazione: (2025)

Is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”
di: Omar Kassar, et al.
Pubblicazione: (2025)

A randomized, double‐blinded, placebo‐controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorder
di: Tempei Otsubo, et al.
Pubblicazione: (2025)

Effects of an 8‐week high‐dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post‐COVID syndrome: A randomized controlled trial
di: Veevarin Charoenporn, et al.
Pubblicazione: (2024)

Magnetic resonance imaging–based machine learning classification of schizophrenia spectrum disorders: a meta‐analysis
di: Fabio Di Camillo, et al.
Pubblicazione: (2024)

Linking autism risk genes to morphological and pharmaceutical screening by high‐content imaging: Future directions and opinion
di: Reza K. Arta, et al.
Pubblicazione: (2025)

Response to [Comment on is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”]
di: Omar Kassar, et al.
Pubblicazione: (2025)

Dynamic cognitive differences between internal and external attention are associated with depressive and anxiety symptoms
di: Taiki Oka, et al.
Pubblicazione: (2025)

Efficacy and safety of each class of sleep medication for major depressive disorder with insomnia symptoms: A systematic review and meta‐analysis of double‐blind randomized controlled trials
di: Taku Maruki, et al.
Pubblicazione: (2025)

Smartphone cognitive behavioral therapy for prevention of depressive symptoms in patients with recurrent pregnancy loss: an exploratory decentralized, parallel‐group, multicenter, open, individually randomized, fully factorial trial
di: Sakura Ogasawara, et al.
Pubblicazione: (2025)

Comparison of multiple non‐invasive neuromodulation strategies for depressive episodes in major depressive disorder and bipolar disorder: A systematic review and network meta‐analysis of randomized controlled trials
di: Ping Wang, et al.
Pubblicazione: (2025)

Associations between self‐reported parasomnias and psychiatric illness in 370,000 patients with sleep disorders
di: Umaer Hanif, et al.
Pubblicazione: (2024)

Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation
di: Tien‐Wei Hsu, et al.
Pubblicazione: (2026)